10/10/2013
In order to provide a more translational readout from preclinical disease models of MS, we have validated single-photon emission computed tomography (SPECT/CT) imaging for non-invasive longitudinal quantification of neuroinflammation in in vivo preclinical MS rat models.
10/07/2013
Charles River is pleased to announce that it has acquired BRASS Pte Ltd (“BRASS”). Building on the partnership established with BRASS in 1997, Charles River aims to accelerate the growth of its portfolio of products and services in Asia by providing clients with state-of-the-art microbial detection and identification for manufacturing in the biopharmaceutical, medical device and life sciences industries.
10/07/2013
The Golden Syrian hamster is a well-established species for the study of lipoprotein profiles. It translates to human outcomes because the species carries the cholesteryl ester transfer protein (CETP).
10/01/2013
In addition to expanded production capacity for New Zealand White rabbits, we can also provide diet acclimation options to meet your study goals.
09/12/2013
We are pleased to announce the relocation of our European endotoxin and microbial detection services to a redesigned, larger facility in Ecully, France and the opening of a brand new facility in Seoul, South Korea.
09/10/2013
Intranasal dosing has been used successfully in several toxicology studies in support of clinical trials ranging from acute to chronic. Recently, we have significantly increased the total volume of test items that can be administered via this route.
09/09/2013
We are pleased to welcome Dr. Wendell Davis, former Director and Head of the Comparative Pathology and Discovery Toxicology at Biogen Idec, and Dr. Matthew Smith, former veterinary pathologist at Bristol-Myers Squibb, to Charles River. Their collective experience and knowledge of the industry adds significant value to our pathology team.
09/02/2013
We have made changes to our standard dual catheterization surgical procedure so that both catheters exit a single midline incision. By using one exit point, we will reduce any unnecessary trauma to the model.
08/28/2013
Our new pain models focus on neuropathic, inflammatory and chronic joint pain indications and provide quantitative behavioral endpoints for developing new pain medications. They assist researchers in assessing and increasing translatability between discovery and first-in-human studies.
08/21/2013
Radio Frequency Identification (RFID) for animal identification can save 50% more time than the standard use of tattoo and resolves issues and procedural errors due to identification problems.